The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Humanigen, Inc. on February 17, 2024. The debtor has been authorized to sell substantially all its assets to Taran Therapeutics Inc., the stalking horse bidder, for a purchase price of $2 million in cash along with a credit bid and the assumption of Liabilities The debtor did not receive any other competing bids for the purchase of its assets and therefore Taran Therapeutics Inc emerged as the winning bidder.